El CRAI romandrà tancat del 24 de desembre de 2025 al 6 de gener de 2026. La validació de documents es reprendrà a partir del 7 de gener de 2026.
El CRAI permanecerá cerrado del 24 de diciembre de 2025 al 6 de enero de 2026. La validación de documentos se reanudará a partir del 7 de enero de 2026.
From 2025-12-24 to 2026-01-06, the CRAI remain closed and the documents will be validated from 2026-01-07.
 
Carregant...
Miniatura

Tipus de document

Article

Versió

Versió publicada

Data de publicació

Llicència de publicació

cc-by (c) Martínez, Ramón et al., 2014
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/113565

DNA methylation alterations in grade II- and anaplastic pleomorphic xanthoastrocytoma

Títol de la revista

Director/Tutor

ISSN de la revista

Títol del volum

Resum

Background: Pleomorphic xanthoastrocytoma (PXA) is a rare WHO grade II tumor accounting for less than 1% of all astrocytomas. Malignant transformation into PXA with anaplastic features, is unusual and correlates with poorer outcome of the patients. Methods: Using a DNA methylation custom array, we have quantified the DNA methylation level on the promoter sequence of 807 cancer-related genes of WHO grade II (n = 11) and III PXA (n = 2) and compared to normal brain tissue (n = 10) and glioblastoma (n = 87) samples. DNA methylation levels were further confirmed on independent samples by pyrosequencing of the promoter sequences. Results: Increasing DNA promoter hypermethylation events were observed in anaplastic PXA as compared with grade II samples. We further validated differential hypermethylation of CD81, HCK, HOXA5, ASCL2 and TES on anaplastic PXA and grade II tumors. Moreover, these epigenetic alterations overlap those described in glioblastoma patients, suggesting common mechanisms of tumorigenesis. Conclusions: Even taking into consideration the small size of our patient populations, our data strongly suggest that epigenome-wide profiling of PXA is a valuable tool to identify methylated genes, which may play a role in the malignant progression of PXA. These methylation alterations may provide useful biomarkers for decision-making in those patients with low-grade PXA displaying a high risk of malignant transformation.

Matèries (anglès)

Citació

Citació

MARTÍNEZ, Ramón, CARMONA, F. javier, VIZOSO, Miguel, ROHDE, Veit, KIRSCH, Matthias, SCHACKERT, Gabriele, ROPERO, Santiago, PAULUS, Werner, BARRANTES, Alonso, GÓMEZ, Antonio, ESTELLER, Manel. DNA methylation alterations in grade II- and anaplastic pleomorphic xanthoastrocytoma. _BMC Cancer_. 2014. Vol. 14, núm. 213. [consulta: 7 de gener de 2026]. ISSN: 1471-2407. [Disponible a: https://hdl.handle.net/2445/113565]

Exportar metadades

JSON - METS

Compartir registre